The evolution and influencing factors of Chinese foreign trade structure of pharmaceutical products

doi:10.3969/j.issn.1004-9479.2024.10.20230064

Abstract

Abstract:

The development of pharmaceutical products and foreign trade cooperation are facing more and more serious challenges under the intertwined influence of emergencies such as the reshaping of the international value chain and COVID-19 infection. Based on the foreign trade data of Chinese pharmaceutical products, using the trade complementarity index and panel regression model, this paper studied the space evolution and influencing factors of the trade structure of Chinese pharmaceutical products from 2001 to 2021. The results show that the scale of foreign trade "starts low and grows fast", the trade deficit continues to increase, antibiotics have the most comparative advantages, and hormones have the most comparative disadvantages; In terms of spatial pattern, Chinese imports and exports are highly dependent on developed countries and regions in Europe and north America. Developing countries or regions also play a part in Chinese export. In terms of the impact mechanism, the gross domestic product, innovation input and output, aging and multi-dimensional proximity of trading countries are positively correlated with Chinese pharmaceutical product trade, and the degree of regional stability is negatively correlated with it. The impact of foreign direct investment is not significant. At the end of the article, the author provides relevant suggestions for the development of Chinese pharmaceutical industry from the perspective of trade market.

Key words: pharmaceutical products, foreign trade, product structure, space-time evolution, influencing factor

摘要：

医药产品是人类生命健康的重要保障和未来经济发展的重要引擎。在国际产业链重塑和新冠病毒感染等突发事件的交织影响下，医药产品发展和对外贸易合作面临愈加严重的挑战。通过中国医药产品对外贸易数据，利用贸易互补指数和面板回归模型，研究2001—2021年中国医药产品对外贸易结构时空演化与影响因素。结果表明：对外贸易规模“起步低，增长快”，贸易逆差不断增大，抗生素最具有比较优势，激素类最具有比较劣势；在空间格局上，中国进口高度依赖于欧美发达国家和地区，出口向欧美稳步拓展的同时也向发展中国家（地区）不断辐散；在影响机制上，贸易国国内生产总值、创新投入和产出、老龄化与多维邻近性和中国医药产品贸易呈正相关，地区稳定程度与之呈负相关，外商直接投资影响不显著。最后从贸易市场的角度对中国医药产业发展提供相关建议。

关键词: 医药, 对外贸易, 产品结构, 时空演化, 影响因素

Yuqun WANG, Qifan XIA. The evolution and influencing factors of Chinese foreign trade structure of pharmaceutical products[J]. World Regional Studies, 2024, 33(10): 71-82.

王煜群, 夏启繁. 中国医药产品对外贸易空间结构演化与影响因素[J]. 世界地理研究, 2024, 33(10): 71-82.

Figures/Tables 6

References 44

1	杜德斌.全球科技创新中心:世界趋势与中国的实践.科学,2018,70(6):15-18.
	DU D. Global science and technology innovation center: World trends and China's practice. Science, 2018, 70(6): 15-18.
2	华东师范大学全球创新与发展研究院. 中美科技竞争力发展报告. 上海: 华东师范大学出版社, 2022.
	Institute for Global Innovation & Development, East China Normal University. China- U.S. Science and Technology Competitiveness Assessment Report. Shanghai: East China Normal University Press, 2022.
3	杜德斌,易鑫磊,马亚华等."心脏地带"理论与俄乌冲突.世界地理研究,2022,31(04):673-686.
	DU D, YI X, MA Y, et al.The heartland theory and the Russia-Ukraine conflict.World Regional Studies,2022,31(4):673-686.
4	曹宛鹏,杜德斌,夏启繁,等.全球COVID-19疫苗开发流通与接种的时空分异特征.地理学报,2022,77(6):1546-1562.
	CAO W, DU D, XIA Q, et al.Spatial and temporal differentiation of global COVID-19 vaccine development, circulation and vaccination. Acta Geographica Sinica,2022, 77 (6): 1546-1562.
5	刘泉红,刘方.中国医药产业发展及产业政策现状、问题与政策建议.经济研究参考,2014(32):39-67.
	LIU Q, LIU F. Chinese pharmaceutical industry development and industrial policy status, problems and policy recommendations . Economic Research Reference, 2014(32): 39-67.
6	World Trade Organization (WTO). Trade in Medical Goods in the Context of Tackling COVID-19 (2020-04-03)[2023-02-12].
7	方悦,唐梦雪,丰志培.全球参类药材贸易网络的特征分析.南京中医药大学学报(社会科学版),2022,23(5):316-323.
	FANG Y, TANG M, FENG Z. Analysis of the characteristics of the global ginseng medicine trade network. Journal of Nanjing University of Traditional Chinese Medicine (Social Science Edition), 2022,23(5): 316-323.
8	丁春玲.RCEP背景下我国药品出口的机遇、挑战及对策研究.产业创新研究,2021,70(17):94-96.
	DING C. Research on the opportunities, challenges and countermeasures of China's drug export in the context of RCEP. Industrial Innovation Research, 2021,70(17): 94-96.
9	朱孟珏,庄大昌.2001—2015年全球健康产业贸易网络特征研究.人文地理, 2018, 33(2): 76-83.
	ZHU M, ZHUANG D.Study on the characteristics of global health industry trade network in 2001—2015. Human Geography, 2018, 33(2): 76-83.
10	钱景怡,余正.我国生物制药产业国际竞争力分析.中国药事,2020,34(5):549-555.
	QIAN J, YU Z. On the international competitiveness of China's bio-pharmaceutical industry. China Pharmaceutical Affairs, 2020,34 (5): 549-555.
11	邓荣,杨修.中国欧盟医药商品贸易:结构特征与发展对策.国际经济合作,2015(2):66-70.
	DENG R, YANG X. China-EU pharmaceutical commodity trade: Structural characteristics and development strategies. International Economic Cooperation, 2015(2): 66-70.
12	王曼,熊尧,余正.美国技术贸易壁垒对中国药品出口影响的实证分析.上海医药,2013,34(9):57-60.
	WANG M, XIONG Y, YU Z. Empirical analysis of the impact of US technical barriers to trade on China's drug exports . Shanghai Pharmaceutical, 2013,34(9): 57-60.
13	徐惟,卜海.技术贸易壁垒对技术创新和出口贸易的倒逼机制.经济与管理研究,2018,39(3):77-88.
	XU W, BU H. The reverse mechanism of technical barriers to trade on technological innovation and export trade . Economic and Management Research, 2018,39(3): 77-88.
14	王桂贤.我国药品出口面临的贸易壁垒及应对之策.对外经贸实务,2017,336(1):38-40.
	WANG G. Trade barriers faced by China's drug export and countermeasures . Practice in Foreign Economic Relations and Trade, 2017,336(1): 38-40.
15	赵霞.中国与俄罗斯医药贸易发展障碍及升级途径.对外经贸实务,2017(12):53-55.
	ZHAO X. Obstacles to the development and upgrading of pharmaceutical trade between China and Russia . Practice in Foreign Economic Relations and Trade, 2017(12): 53-55.
16	李振吉,黄建银,邱珺, 等.金砖国家中医药技术性贸易壁垒及应对策略研究.世界中医药,2013,8(8):887-890.
	LI Z, HUANG J, QIU J,et al. Research on technical barriers to trade in traditional Chinese medicine in BRICS countries and their countermeasures. World Chinese Medicine, 2013,8(8): 887-890.
17	李娅. 医药产品贸易网络特征及其对出口技术复杂度的影响研究.镇江:江苏大学,2019.
	LI Y Research on the characteristics of pharmaceutical product trade network and its impact on the complexity of export technology.Zhenjiang: Jiangsu University, 2019.
18	郭浩. 中国对印度药品出口贸易潜力分析.石家庄: 河北经贸大学,2022.
	GUO H. Analysis of China's pharmaceutical export trade potential to India.Shijiazhuang: Hebei University of Economics and Business, 2022.
19	贾凤. 全球价值链视角下中国医药产业国际竞争力研究.昆明: 昆明理工大学,2022.
	JIA F. Research on the international competitiveness of Chinese pharmaceutical industry from the perspective of global value chain.Kunming: Kunming University of Science and Technology, 2022.
20	崔庆云. 中美医药产品产业内贸易影响因素分析.上海: 上海社会科学院,2017.
	CUI Q. Analysis of factors affecting intra-industry trade of Sino-US pharmaceutical products.Shanghai: Shanghai Academy of Social Sciences, 2017.
21	曹悦. 我国医药企业海外市场进入模式研究.北京: 北京林业大学,2018.
	CAO Y. Research on the overseas market entry mode of Chinese pharmaceutical enterprises.Beijing : Beijing Forestry University, 2018.
22	万媛媛, 王秋玉, 曾刚, 等.高校与医药企业创新结网的影响机制——以长三角为例.经济地理,2022,42(7):146-158.
	WAN Y, WANG Q, ZENG G, et al. The impact mechanism of innovative networking between universities and biomedical enterprises - Taking the Yangtze River Delta as an example . Economic Geography, 2022, 42(7): 146-158.
23	夏启繁,杜德斌. 21世纪海上丝绸之路能源贸易结构及与中国的贸易关系演变.地理研究,2022,41(7):1797-1813.
	XIA Q, DU D.Evolution of energy trade structure in the 21st Century Maritime Silk Road and its trade relations with China. Geographical Research, 2022,41(7): 1797-1813.
24	段德忠,杜德斌.全球高科技产品贸易结构演化及影响因素.地理学报, 2020, 75(12):2759-2776.
	DUAN D, DU D. Structural evolution of global high-tech trade system: Products, networks and influencing factors. Acta Geographica Sinica, 2020, 75(12):2759-2776.
25	黄晓东,杜德斌,覃雄合,等."一带一路"沿线跨境技术并购网络格局演化特征——以高科技企业标的为例.地理研究,2022,41(5):1352-1370.
	HUANG X, DU D, QIN X, et al. The evolution process of cross-border technological M&A network along the Belt and Road: Based on the data of high-tech enterprise targets.Geographical Research, 2022, 41(5) :1352-1370.
26	马彦. 生物医药产业价值链的整合化研究.上海: 复旦大学,2007.
	MA Y. Research on the integration of the value chain of the biomedical industry.Shanghai: Fudan University, 2007.
27	BALASSA B. Tarriff protection in industrial countries: An evaluation. Journal of Political Economy,1965,73(6):573-594.
28	高红伟.中国数字服务贸易的国际竞争力分析.统计与决策,2023(4):158-162.
	GAO H. Analysis of the international competitiveness of China's digital service trade . Statistics and Decision, 2023(4): 158-162.
29	傅朝阳.中国出口商品比较优势的实证分析:1980—2000.世界经济研究,2005(3):34-39.
	FU C. Empirical analysis of comparative advantages of China's export commodities: 1980-2000 . World Economic Research, 2005(3): 34-39.
30	林涛,黄银锻."一带一路"背景下中印农产品贸易关系分析.亚太经济,2020(3):45-52.
	LIN T, HUANG Y. Analysis of China and India agricultural trade relations in the context of the "the Belt and Road" . Asia Pacific Economy, 2020 (3): 45-52.
31	陈强. 高级计量经济学及Stata应用. 北京: 高等教育出版社, 2014.
	CHEN Q. Advanced Econometrics and Stata Application Beijing: Higher Education Press, 2014.
32	赵晶,陈军.基于面板回归模型的中国棉花产业国际竞争力影响因素分析.河北能源职业技术学院学报,2020,20(2):18-24.
	ZHAO J, CHEN J. Analysis of factors affecting the international competitiveness of China's cotton industry based on panel regression model. Journal of Hebei Energy Vocational and Technical College, 2020,20(2): 18-24.
33	EvaluatePharma. EvaluatePharma World Preview 2019, Outlook to 2024(2019-06-04)[2023-02-12]. .
34	张佳睿.美国生物医药产业发展的经验及启示.商业研究,2015,464(12):24-28.
	ZHANG J. The experience and inspiration of the development of the US biomedical industry . Business Research, 2015,464(12): 24-28.
35	张熊.中国原料药产业的现状与发展.精细与专用化学品,2023,31(1):6-8.
	ZHANG X. Current situation and development of China's API industry . Fine and Specialty Chemicals, 2023,31(1): 6-8.
36	夏启繁,杜德斌,段德忠等.中国稀土对外贸易格局演化及影响因素.地理学报,2022,77(4):976-995.
	XIA Q, DU D, DUAN D, et al. Evolution and influencing factors of China's foreign trade in rare earth metals. Acta Geographica Sinica, 2022, 77(4): 976-995.
37	贾晓朋,吕拉昌.中国文化贸易的影响因素分析——以核心文化产品出口为例.地理科学,2017,37(8):1145-1150.
	JIA X, LYU L. Influence factors of China's cultural trade with exports of core cultural products for example. Scientia Geographica Sinica,2017,37(8):1145-1150.
38	KIM D H. Trade, growth and income. The Journal of International Trade & Economic Development, 2008, 20(5): 677-709.
39	周路.中美食用菌产业内贸易测度与影响因素分析.内蒙古科技与经济,2021(16):30-33.
	ZHOU L. Sino-US edible fungus intra-industry trade measurement and impact factor analysis. Inner Mongolia Science and Technology and Economy, 2021(16): 30-33.
40	张如庆.中国对外直接投资与对外贸易的关系分析.世界经济研究,2005(3):23-27.
	ZHANG R. Analysis of the relationship between China's foreign direct investment and foreign trade. World Economic Research, 2005(3): 23-27.
41	王介勇,戴纯,周墨竹,等.全球粮食贸易网络格局及其影响因素.自然资源学报,2021,36(6):1545-1556.
	WANG J, DAI C, ZHOU M, et al. Research on global grain trade network pattern and its influencing factors. Journal of Natural Resources, 2021, 36(6): 1545-1556.
42	杨文龙,杜德斌."一带一路"沿线国家投资网络结构及其影响因素:基于ERGM模型的研究.世界经济研究,2018, 291(5):80-94.
	YANG W, DU D. Investment network structure and its impact mechanism of the Belt and Road initiative area. World Economy Studies, 2018, 291(5): 80-94.
43	李冉.人口老龄化对制造业贸易影响的文献综述.行政事业资产与财务,2018(24):3-4.
	LI R. Literature review of the impact of population aging on manufacturing trade. Administrative Assets and Finance, 2018(24): 3-4.
44	蔡宏波,韩金镕.人口老龄化与城市出口贸易转型.中国工业经济,2022, 416(11):61-77.
	CAI H, HAN J. Population aging and the transformation of urban export. China Industrial Economics, 2022, 416(11): 61-77.

产品种类	HS商品编码
激素类	300331、300339、300431、300432、300439
抗生素	300310、300320、300410、300420
化学药物	300360、300390、300450、300460、300490
生物碱	300340、300341、300342、300343、300349，300440、300441、300442、300443、300449
疫苗和血液制品	300210、300211、300212、300213、300214、300215、300219、300220

产品种类	HS商品编码
激素类	300331、300339、300431、300432、300439
抗生素	300310、300320、300410、300420
化学药物	300360、300390、300450、300460、300490
生物碱	300340、300341、300342、300343、300349，300440、300441、300442、300443、300449
疫苗和血液制品	300210、300211、300212、300213、300214、300215、300219、300220

年份	激素类		抗生素		化学药物		生物碱		疫苗和血液制品		贸易差额
年份	出口	进口	出口	进口	出口	进口	出口	进口	出口	进口	贸易差额
2001	0.08	0.65	0.65	1.45	2.27	6.37	0.05	0.25	0.03	0.47	－6.11
2003	0.09	2.05	0.66	2.15	2.63	7.39	0.06	0.48	0.20	0.86	－9.29
2005	0.13	3.23	0.98	2.93	3.80	10.25	0.05	0.44	0.11	1.11	－12.88
2007	0.29	6.04	1.82	4.15	6.06	18.81	0.11	0.59	0.23	2.62	－23.70
2009	0.44	10.45	3.58	6.22	7.77	32.43	0.18	0.89	0.68	6.60	－43.94
2011	0.64	17.72	5.49	9.13	17.70	54.52	0.18	1.20	1.54	14.87	－71.89
2013	1.11	23.50	6.15	11.30	22.30	74.42	0.14	1.53	2.81	30.69	－108.93
2015	2.94	26.83	7.17	11.32	24.06	92.91	0.15	1.96	3.66	47.13	－142.17
2017	2.94	32.13	7.60	15.29	25.97	124.08	0.16	2.99	5.15	63.25	－195.94
2019	4.76	39.76	10.03	18.00	30.46	153.58	0.19	3.86	6.23	102.42	－265.94
2021	11.48	40.05	12.50	17.10	38.43	178.74	0.36	3.11	270.46	151.64	－57.41

年份	激素类		抗生素		化学药物		生物碱		疫苗和血液制品		贸易差额
年份	出口	进口	出口	进口	出口	进口	出口	进口	出口	进口	贸易差额
2001	0.08	0.65	0.65	1.45	2.27	6.37	0.05	0.25	0.03	0.47	－6.11
2003	0.09	2.05	0.66	2.15	2.63	7.39	0.06	0.48	0.20	0.86	－9.29
2005	0.13	3.23	0.98	2.93	3.80	10.25	0.05	0.44	0.11	1.11	－12.88
2007	0.29	6.04	1.82	4.15	6.06	18.81	0.11	0.59	0.23	2.62	－23.70
2009	0.44	10.45	3.58	6.22	7.77	32.43	0.18	0.89	0.68	6.60	－43.94
2011	0.64	17.72	5.49	9.13	17.70	54.52	0.18	1.20	1.54	14.87	－71.89
2013	1.11	23.50	6.15	11.30	22.30	74.42	0.14	1.53	2.81	30.69	－108.93
2015	2.94	26.83	7.17	11.32	24.06	92.91	0.15	1.96	3.66	47.13	－142.17
2017	2.94	32.13	7.60	15.29	25.97	124.08	0.16	2.99	5.15	63.25	－195.94
2019	4.76	39.76	10.03	18.00	30.46	153.58	0.19	3.86	6.23	102.42	－265.94
2021	11.48	40.05	12.50	17.10	38.43	178.74	0.36	3.11	270.46	151.64	－57.41

年份	激素类	抗生素	化学药物	生物碱	疫苗和血液制品
2001	0.31	2.43	1.04	1.00	0.09
2002	0.27	2.21	0.94	1.48	1.05
2003	0.28	2.72	0.98	1.29	0.55
2004	0.24	3.62	0.99	1.28	0.19
2005	0.30	3.51	1.05	0.85	0.16
2006	0.30	3.73	1.01	0.47	0.23
2007	0.43	4.19	0.94	1.23	0.27
2008	0.46	5.19	0.92	1.72	0.22
2009	0.44	5.62	0.90	1.53	0.30
2010	0.39	5.75	0.87	1.33	0.42
2011	0.32	4.27	1.06	0.60	0.29
2012	0.34	4.31	1.10	0.32	0.29
2013	0.37	4.13	1.10	0.49	0.37
2014	0.49	4.67	1.12	0.59	0.37
2015	0.91	4.57	1.05	0.26	0.38
2016	0.67	4.80	1.07	0.36	0.50
2017	0.91	4.99	1.14	0.40	0.37
2018	1.08	5.02	1.16	0.30	0.33
2019	1.25	5.53	1.14	0.43	0.33
2020	0.80	4.01	0.75	0.42	1.16
2021	0.48	1.48	0.25	0.16	1.89